Recent Articles

September 23, 2016 3:31 pm
Ryan Bushey
UnitedHealth Group is joining the ranks of insurers opting to prioritize cheaper versions of drugs over their name-brand counterparts.
September 23, 2016 1:00 pm
Government reforms and increased market access will play a role in this growth.
September 23, 2016 8:55 am
Ryan Bushey
Microsoft’s foray into this field signifies the interest in implementing A.I. to synthesize the tremendous amounts of biological data that is now accessible.
September 22, 2016 12:45 pm
Ryan Bushey
New details have emerged over the past few days providing some insight into what the German chemical and pharmaceutical giant has planned.
September 20, 2016 3:06 pm
Dusty Tenney, President, Brooks Life Science Systems
Properly-preserved biological samples, along with their linked clinical data, are valuable assets for the advancement of medical knowledge and the understanding of disease. This has subsequently transformed the way researchers collect, transport and manage samples and their associated data.
September 20, 2016 2:00 pm
Walt Orenstein and Julie Garon, Emory University, The Conversation
Decades of innovation, collaboration and old-fashioned sweat and tears have yielded the fewest polio cases to date.
September 20, 2016 9:23 am
Ryan Bushey
Allergan’s acquisition spree continued on Tuesday with the announcement it bought Tobira Therapeutics in a deal worth up to $1.7 billion.
September 19, 2016 3:53 pm
Ryan Bushey
Vice President Joe Biden’s vision for his Cancer Moonshot project is slowly coming into focus.
September 19, 2016 4:10 pm
Ryan Bushey
The Swiss drug maker could have a strong contender to treating a rare form of multiple sclerosis.
September 16, 2016 12:04 pm
Ryan Bushey
The Danish drug maker's once-weekly injectable therapy hit an important milestone in a recent study.
Subscribe to Drug Discovery & Development